About Inbiomotion
Inbiomotion is a company based in Barcelona (Spain) founded in 2010.. Inbiomotion has raised $4.91 million across 5 funding rounds from investors including European Commission, European Union and Alta Life Sciences. Inbiomotion operates in a competitive market with competitors including OncoStem, Curasight, PreludeDx, Miltel and POC Medical Systems, among others.
- Headquarter Barcelona, Spain
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.91 M (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
European Commission
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Leadership Team
4 people
Advisor Team
3 people
Advisory Team
1 people
Founder Team
1 people
Unlock access to complete
Funding Insights of Inbiomotion
Inbiomotion has successfully raised a total of $4.91M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(28 Jun 2012)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Series A - Inbiomotion | Valuation | Alta Life Sciences |
|
| Mar, 2016 | Amount | Series A - Inbiomotion | Valuation | Caixa Capital Risc | |
| Mar, 2016 | Amount | Grant - Inbiomotion | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Inbiomotion
Inbiomotion has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include European Commission, European Union and Alta Life Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Ysios Capital is recognized as a leading life sciences investor.
|
Founded Year | Domain | Location | |
|
Venture capital investments are focused on healthcare and multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Inbiomotion
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Inbiomotion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Inbiomotion Comparisons
Competitors of Inbiomotion
Inbiomotion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OncoStem, Curasight, PreludeDx, Miltel and POC Medical Systems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Prognostic tests for cancer detection and recurrence risk are developed.
|
|
| domain | founded_year | HQ Location |
uPAR-based PET ligands for breast cancer imaging are developed.
|
|
| domain | founded_year | HQ Location |
Risk assessment tests for early-stage breast cancer are provided.
|
|
| domain | founded_year | HQ Location |
Telomere tests for aging detection and cellular senescence are provided.
|
|
| domain | founded_year | HQ Location |
Develops rapid tools for breast cancer detection and disease screening worldwide.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Inbiomotion
Frequently Asked Questions about Inbiomotion
When was Inbiomotion founded?
Inbiomotion was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Where is Inbiomotion located?
Inbiomotion is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Is Inbiomotion a funded company?
Inbiomotion is a funded company, having raised a total of $4.91M across 5 funding rounds to date. The company's 1st funding round was a Grant of $54.36K, raised on Jun 28, 2012.
What does Inbiomotion do?
Inbiomotion was founded in 2010 in Barcelona, Spain, within the biotechnology sector. Biomarkers are developed by the company to predict bone metastasis risks in cancer patients. A specific biomarker was identified in primary breast tumors to forecast bone relapse, regardless of other clinical parameters. This approach is currently being evaluated across multiple solid tumor types.
Who are the top competitors of Inbiomotion?
Who are Inbiomotion's investors?
Inbiomotion has 6 investors. Key investors include European Commission, European Union, Alta Life Sciences, Ysios Capital, and Caixa Capital Risc.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.